Modelled DT Structure
Method: multi-sequence alignment based machine learning
Detail: Structure Info
General Information of DT | |||||
---|---|---|---|---|---|
DT ID | DTD0127 | ||||
Gene Name | SLC19A2 | ||||
Protein Name | Thiamine transporter 1 | ||||
Gene ID | |||||
UniProt ID | |||||
TCDB ID | |||||
3D Structure |
Modelled DT Structure Method: multi-sequence alignment based machine learning Detail: Structure Info |
||||
Synonyms | SLC19A2; Solute carrier family 19 member 2; TC1; THMD1; THT1; TRMA; ThTr-1; ThTr1; Thiamine carrier 1 | ||||
DT Family | Reduced Folate Carrier (RFC) Family ; | ||||
Tissue Specificity | Ubiquitous; most abundant in skeletal andcardiac muscle. Medium expression in placenta, heart, liver andkidney, low in lung. | ||||
Function | This transporter is high-affinity transporter for the intake of thiamine. | ||||
Endogenous Substrate(s) | Thiamine | ||||
Variability Data of This Drug Transporter (DT) | |||||
Regulatory Variability Data of This DT (VARIDT 3.0) |
|||||
(β) Post-translational Modification of This DT |
|||||
(γ) Transcriptional Regulation of This DT |
|||||
(δ) Epigenetic Regulation of This DT |
|||||
(ε) Exogenous Modulation of This DT |
|||||
Structural Variability Data of This DT (VARIDT 2.0) |
|||||
(β) Inter-species Structural Differences |
|||||
General Variability Data of This DT (VARIDT 1.0) |
|||||
(β) Disease-specific Protein Abundances of This DT |
|||||
(γ) Species- and Tissue-specific DT Abundances |
|||||
Molecular Transporting Profile of This DT | |||||
Full List of Drug(s) Transported by This DT |
|||||
Approved Drug |
Click to Show/Hide the Full List of Drug: 1 Drugs in Total | ||||
Drug Name | Highest Status | Detail | Indication | ICD 11 | Ref |
Metformin
|
Approved | Drug Info | Type 2 diabetes | 5A11 | [1] |
Endogenous Metabolites (EMs) Handled by This DT |
|||||
Endogenous Metabolites (EMs) |
Click to Show/Hide the Full List of EMs: 1 EMs in Total | ||||
EM Name | PubChem CID | Detail | Experimental Material | Ref | |
Thiamine | EM Info | Identified using miR-155 Knockout MCF7 cells | [2] | ||
References | |||||
1 | Metformin Is a Substrate and Inhibitor of the Human Thiamine Transporter, THTR-2 (SLC19A3). Mol Pharm. 2015 Dec 7;12(12):4301-10. | ||||
2 | Bioinformatic and metabolomic analysis reveals miR-155 regulates thiamine level in breast cancer. Cancer Lett. 2015 Feb 28;357(2):488-97. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.